Shares of Cupid rose 8.8% in two days to Rs 289.95 on the BSE on Wednesday, after the contraceptive-maker reported a threefold surge in net profit for the April-June quarter of the ongoing financial year 2027.The company reported a consolidated net profit of Rs 44 crore for the first quarter of FY27, compared with Rs 15 crore in the corresponding quarter of the previous financial year. The firm’s revenue from operations rallied 159% year-on-year (YoY) to Rs 155 crore during the quarter under review.The company’s EBITDA rallied 265% YoY to Rs 60 crore, while the EBITDA margin improved 1,127 bps to 39% during the quarter. Cupid began FY27 with strong momentum across its international B2B healthcare and domestic consumer healthcare and FMCG businesses, supported by healthy execution across key operating segments, it said.Cupid has implemented a minimum 10% price increase across its export portfolio, supporting improved realisations and margin expansion, while a favourable USD/INR exchange-rate environment has supported export realisations, it said. Supported by a strong order book, expanding consumer healthcare and FMCG portfolio, healthy international B2B demand and expectations of robust performance during the second half of FY27, Cupid has increased its FY27 guidance to Rs 725-750 crore in revenue and Rs 210-225 crore in net profit.Strong growth in operating income reflects the increasing contribution of its core operating businesses, reinforcing the quality of earnings and the sustainability of its growth trajectory, Cupid said in its press release. The company added that it expects sizeable orders across its IVD Kits portfolio from multiple state governments in India, along with significant international opportunities following the receipt of CE certifications. Several opportunities are in the final stages of the award process, providing a strong near-term growth pipeline.What management saidLooking ahead, Cupid remains focused on disciplined execution, maintaining healthy margins and building a future-ready organisation through continued investments in manufacturing, product innovation, international B2B healthcare and consumer healthcare and FMCG businesses, said Aditya Kumar Halwasiya, Chairman and Managing Director, Cupid.Halwasiya said these strategic initiatives position Cupid to deliver sustainable long-term growth and create enduring value for all its stakeholders.Also Read | Cupid shares fall 2% even as Q1 profit jumps 3x. What’s ahead for multibagger stock that rose 680% in a year?Cupid Share PriceShares of Cupid gained nearly 5% to trade at Rs 289.95 on the BSE on Wednesday. The shares have gained 24% in a month and are up 150% so far in 2026. In the longer term, the stock has delivered a whopping 683% return over one year, 8,923% in three years and 10,979% in five years.The company currently has a market capitalisation of more than Rs 35,191 crore.(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of The Economic Times.)